1 year return (CAGR)
-67.55%
Satsuma Pharmaceuticals Inc Exchange (NASDAQ, USD)
STSA
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-66.25%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
36.47M
Price/Sales
-
Ent value
22.77M
Price/Book
0.97
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
23.22%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 1.10 |
| Daily high | 1.10 |
| Daily low | 1.10 |
| Daily Volume | 0K |
| 1y analyst estimate | 2.00 |
| Beta | 0.10 |
| EPS (TTM) | -1.91 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| STSA | S&P500 | |
| Current price drop from All-time high | -96.83% | -10.01% |
| Highest price drop | -98.24% | -56.47% |
| Date of highest drop | 16 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -70.44% | -10.68% |
| Avg time to new high | 47 days | 12 days |
| Max time to new high | 748 days | 1805 days |
News
No items found